マイクロバイオームシーケンスサービス市場：技術、用途、エンドユーザー別-世界予測2025-2030年

マイクロバイオームシーケンスサービス市場は、2023年に17億8,000万米ドルと評価され、2024年には20億4,000万米ドルに達すると予測され、CAGR 14.80％で成長し、2030年には47億米ドルになると予測されています。

マイクロバイオームシーケンスサービスでは、人体、土壌、水系など様々な環境に存在する微生物群集の遺伝物質を解析します。このサービスは、健康、農業、環境の持続可能性に重要な役割を果たす微生物の複雑な相互作用と機能を理解するために不可欠です。マイクロバイオームシーケンスの必要性は、病気の予測や治療の最適化を支援する個別化医療や、農作物の生産性や土壌の健全性を高める農業への応用によって強調されています。主なエンドユーザーには、製薬会社、研究機関、農業団体、環境機関などが含まれます。市場成長の主な原動力は、慢性疾患の有病率の増加、精密医療への関心の高まり、シーケンス技術の進歩、マイクロバイオームが健康と病気に与える影響に対する意識の高まりです。新興国市場への進出、費用対効果が高く高速なシーケンス技術の開拓、より優れたデータ解析と解釈のための人工知能の統合にビジネスチャンスがあります。しかし、高額なコスト、複雑なデータ管理、遺伝情報に関するプライバシーの問題などが課題となっています。こうした制約を克服するためには、簡素化されたコスト効率の高いシーケンス手法や安全なデータ共有プラットフォームの開発における技術革新が有益であろう。微生物に基づく治療薬の開発などの分野では、新しいアプリケーションが次々と登場しており、大きな成長の可能性があります。高度なデータ分析のためのハイテク企業との提携や協力への投資、研究開発努力の拡大が推奨される戦略です。市場のダイナミックで急速な進化を考えると、企業は競争力を強化するために、オーダーメイドのソリューションを提供し、学術的・臨床的パートナーとの強力なネットワークを確立することに注力すべきです。さらに、規制への対応とマイクロバイオーム研究の利点に関する社会教育が、市場の拡大と受容において極めて重要な役割を果たすと思われます。

市場力学：急速に進化するマイクロバイオームシーケンスサービス市場の主要市場インサイトを公開

マイクロバイオームシーケンスサービス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 疾患の早期発見のためのマイクロバイオームシーケンシングの必要性
  • マイクロバイオームシーケンスの認知拡大を目指す政府の取り組み
  • マイクロバイオームシーケンス活動におけるサードパーティサービスの採用
• 市場抑制要因
  • 標準化された手順の欠如とサンプル収集のばらつき
• 市場機会
  • マイクロバイオームシーケンスの技術的進歩
  • サービス向上のための戦略的提携
• 市場の課題
  • マイクロバイオームシーケンスに関連する規制および倫理的懸念

ポーターの5つの力：マイクロバイオームシーケンスサービス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：マイクロバイオームシーケンスサービス市場における外部からの影響の把握

外部マクロ環境要因は、マイクロバイオームシーケンスサービス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析マイクロバイオームシーケンスサービス市場における競合情勢の把握

マイクロバイオームシーケンスサービス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスマイクロバイオームシーケンスサービス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、マイクロバイオームシーケンスサービス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨マイクロバイオームシーケンスサービス市場における成功への道筋を描く

マイクロバイオームシーケンスサービス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 病気の早期発見のためのマイクロバイオーム配列解析の必要性
    • マイクロバイオーム配列の認知度を高める政府の取り組み
    • マイクロバイオームシークエンシング活動のためのサードパーティサービスの採用
  • 抑制要因
    • 標準化された手順の欠如とサンプル収集のばらつき
  • 機会
    • マイクロバイオーム配列解析における技術的進歩
    • より良いサービスを提供するためのプレーヤー間の戦略的パートナーシップ
  • 課題
    • マイクロバイオームの配列解析に関連する規制と倫理上の懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 マイクロバイオームシーケンスサービス市場：技術別

• パイロシーケンス
• RNAシークエンシング
• サンガーシーケンス
• ライゲーションによる配列決定
• 合成による配列決定
• ショートガンシーケンス
• 標的遺伝子配列決定

第7章 マイクロバイオームシーケンスサービス市場：用途別

• 中枢神経疾患
• 胃腸疾患
• 感染症
• 腫瘍学

第8章 マイクロバイオームシーケンスサービス市場：エンドユーザー別

• 製薬・バイオテクノロジー企業
• 調査・学術機関

第9章 南北アメリカのマイクロバイオームシーケンスサービス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のマイクロバイオームシーケンスサービス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのマイクロバイオームシーケンスサービス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• BaseClearBV
• BGI Genomics Co., Ltd.
• BioAro
• Biomcare ApS
• CD Genomics
• Charles River Laboratories.
• ClinicalMicrobiomicsA/S
• CosmosID
• Diversigen,Inc by OraSure Technologies
• Epistem Ltd.
• Eurofins Genomics
• EzBiome by CJ BIOSCIENCE COMPANY
• Genewiz by Azenta Life Sciences
• Illumina Inc.
• Macrogen, Inc.
• MerieuxNutriSciencesCorporation
• Microbiome Insights Inc.
• Molzym GmbH & Co. Kg
• Mr. DNA Lab
• Pacific Biosciences of California, Inc.
• Psomagen,Inc
• QIAGEN
• RanchoBiosciences
• Resphera Biosciences, LLC
• SeqMatic LLC.
• Sequentia Biotech SL
• Shanghai Realbio Technology Co., Ltd,
• Viome Life Sciences, Inc.
• Zifo Technologies Private Limited
• ZymoResearchCorp

LIST OF FIGURES

• FIGURE 1. MICROBIOME SEQUENCING SERVICES MARKET RESEARCH PROCESS
• FIGURE 2. MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. MICROBIOME SEQUENCING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. MICROBIOME SEQUENCING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. MICROBIOME SEQUENCING SERVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. MICROBIOME SEQUENCING SERVICES MARKET DYNAMICS
• TABLE 7. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PYRO SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SEQUENCING BY LIGATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY SHORT GUN SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TARGETED GENE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY CNS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY GASTRO-INTESTINAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. CANADA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 34. CANADA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. CANADA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. CHINA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. CHINA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. CHINA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. INDIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. INDIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. INDIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 105. ITALY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. ITALY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. ITALY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. POLAND MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. POLAND MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. POLAND MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. QATAR MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 121. QATAR MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. QATAR MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM MICROBIOME SEQUENCING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 150. MICROBIOME SEQUENCING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 151. MICROBIOME SEQUENCING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Microbiome Sequencing Services Market was valued at USD 1.78 billion in 2023, expected to reach USD 2.04 billion in 2024, and is projected to grow at a CAGR of 14.80%, to USD 4.70 billion by 2030.

Microbiome sequencing services involve analyzing the genetic material of microbial communities found in various environments, such as the human body, soil, or aquatic systems. This service is essential for understanding the complex interactions and functions of microorganisms that play crucial roles in health, agriculture, and environmental sustainability. The necessity of microbiome sequencing is underscored by its applications in personalized medicine, where it aids in disease prediction and treatment optimization, as well as in agriculture for enhancing crop productivity and soil health. Key end-users include pharmaceutical companies, research institutions, agricultural entities, and environmental agencies. Market growth is primarily driven by the increasing prevalence of chronic diseases, growing interest in precision medicine, advancements in sequencing technology, and rising awareness of the microbiome's impact on health and disease. Opportunities lie in expanding into emerging markets, developing cost-effective and faster sequencing technologies, and integrating artificial intelligence for better data analysis and interpretation. However, factors such as high costs, complex data management, and privacy concerns regarding genetic information pose challenges. To overcome these limitations, innovating in the development of simplified, cost-efficient sequencing methodologies and secure data-sharing platforms could be beneficial. The continuous emergence of new applications in areas such as the development of microbiome-based therapeutics presents significant growth potential. Investing in partnerships and collaborations with tech companies for advanced data analytics and expansion of R&D efforts are recommended strategies. Given the dynamic and rapidly evolving nature of the market, businesses should focus on providing tailored solutions and establishing strong networks with academic and clinical partners to enhance competitiveness. Additionally, regulatory compliance and public education on the benefits of microbiome research will play a pivotal role in market expansion and acceptance.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Microbiome Sequencing Services Market

The Microbiome Sequencing Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Need for microbiome sequencing for early detection of diseases
  • Government initiatives to expand the awareness of microbiome sequencing
  • Adoption of third-party services for microbiome sequencing activities
• Market Restraints
  • Lack of standardized procedures and variations in sample collection
• Market Opportunities
  • Technological advancements in microbiome sequencing
  • Strategic partnerships of players to provide improved services
• Market Challenges
  • Regulatory and ethical concerns associated with microbiome sequencing

Porter's Five Forces: A Strategic Tool for Navigating the Microbiome Sequencing Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Microbiome Sequencing Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Microbiome Sequencing Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Microbiome Sequencing Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Microbiome Sequencing Services Market

A detailed market share analysis in the Microbiome Sequencing Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Microbiome Sequencing Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Microbiome Sequencing Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Microbiome Sequencing Services Market

A strategic analysis of the Microbiome Sequencing Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Microbiome Sequencing Services Market, highlighting leading vendors and their innovative profiles. These include BaseClearBV, BGI Genomics Co., Ltd., BioAro, Biomcare ApS, CD Genomics, Charles River Laboratories., ClinicalMicrobiomicsA/S, CosmosID, Diversigen,Inc by OraSure Technologies, Epistem Ltd., Eurofins Genomics, EzBiome by CJ BIOSCIENCE COMPANY, Genewiz by Azenta Life Sciences, Illumina Inc., Macrogen, Inc., MerieuxNutriSciencesCorporation, Microbiome Insights Inc., Molzym GmbH & Co. Kg, Mr. DNA Lab, Pacific Biosciences of California, Inc., Psomagen,Inc, QIAGEN, RanchoBiosciences, Resphera Biosciences, LLC, SeqMatic LLC., Sequentia Biotech SL, Shanghai Realbio Technology Co., Ltd,, Viome Life Sciences, Inc., Zifo Technologies Private Limited, and ZymoResearchCorp.

Market Segmentation & Coverage

This research report categorizes the Microbiome Sequencing Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Pyro Sequencing, RNA Sequencing, Sanger Sequencing, Sequencing by Ligation, Sequencing by Synthesis, Short Gun Sequencing, and Targeted Gene Sequencing.
• Based on Application, market is studied across CNS Diseases, Gastro-Intestinal Diseases, Infectious Diseases, and Oncology.
• Based on End User, market is studied across Pharmaceutical & Biotechnology Companies and Research & Academic Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Need for microbiome sequencing for early detection of diseases
    • 5.1.1.2. Government initiatives to expand the awareness of microbiome sequencing
    • 5.1.1.3. Adoption of third-party services for microbiome sequencing activities
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of standardized procedures and variations in sample collection
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in microbiome sequencing
    • 5.1.3.2. Strategic partnerships of players to provide improved services
  • 5.1.4. Challenges
    • 5.1.4.1. Regulatory and ethical concerns associated with microbiome sequencing
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Microbiome Sequencing Services Market, by Technology

• 6.1. Introduction
• 6.2. Pyro Sequencing
• 6.3. RNA Sequencing
• 6.4. Sanger Sequencing
• 6.5. Sequencing by Ligation
• 6.6. Sequencing by Synthesis
• 6.7. Short Gun Sequencing
• 6.8. Targeted Gene Sequencing

7. Microbiome Sequencing Services Market, by Application

• 7.1. Introduction
• 7.2. CNS Diseases
• 7.3. Gastro-Intestinal Diseases
• 7.4. Infectious Diseases
• 7.5. Oncology

8. Microbiome Sequencing Services Market, by End User

• 8.1. Introduction
• 8.2. Pharmaceutical & Biotechnology Companies
• 8.3. Research & Academic Institutes

9. Americas Microbiome Sequencing Services Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Microbiome Sequencing Services Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Microbiome Sequencing Services Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. BaseClearBV
• 2. BGI Genomics Co., Ltd.
• 3. BioAro
• 4. Biomcare ApS
• 5. CD Genomics
• 6. Charles River Laboratories.
• 7. ClinicalMicrobiomicsA/S
• 8. CosmosID
• 9. Diversigen,Inc by OraSure Technologies
• 10. Epistem Ltd.
• 11. Eurofins Genomics
• 12. EzBiome by CJ BIOSCIENCE COMPANY
• 13. Genewiz by Azenta Life Sciences
• 14. Illumina Inc.
• 15. Macrogen, Inc.
• 16. MerieuxNutriSciencesCorporation
• 17. Microbiome Insights Inc.
• 18. Molzym GmbH & Co. Kg
• 19. Mr. DNA Lab
• 20. Pacific Biosciences of California, Inc.
• 21. Psomagen,Inc
• 22. QIAGEN
• 23. RanchoBiosciences
• 24. Resphera Biosciences, LLC
• 25. SeqMatic LLC.
• 26. Sequentia Biotech SL
• 27. Shanghai Realbio Technology Co., Ltd,
• 28. Viome Life Sciences, Inc.
• 29. Zifo Technologies Private Limited
• 30. ZymoResearchCorp